Evidence map›Paper›PMID 33574884›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Nephroprotective Effects of

Esmaeel Panahi Kokhdan, Hossein Sadeghi, Shima Kazemi, Amir Hossein Doustimotlagh

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Investigating the effect aerials part ofInternational journal of burns and trauma · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Esmaeel Panahi KokhdanMedicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.ORCID https://orcid.org/0000-0002-8470-8844
Hossein SadeghiMedicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.ORCID https://orcid.org/0000-0001-8465-5933
Shima KazemiStudent Research Committee, Yasuj University of Medical Sciences, Yasuj, Iran.ORCID https://orcid.org/0000-0002-5853-8589
Amir Hossein DoustimotlaghMedicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, Iran.ORCID https://orcid.org/0000-0002-9166-419X
Yasuj University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCisplatin (Cis) is an anticancer drug; however, it has dose-dependent renal toxicity. The current study aims to investigate the protective effects of MATERIALS AND

methodsForty-two Wistar male rats were randomly allocated into six groups (

resultThe results revealed that Z.M.B extract, carvacrol, and thymol markedly decreased the renal index as compared with the Cis-only group. Also, carvacrol and thymol significantly reduced the blood urea nitrogen level as compared with the Cis-only group. Furthermore, Z.M.B extract, carvacrol, and thymol significantly attenuated the Cis-induced increase in malondialdehyde and nitric oxide metabolite. Additionally, histopathological examination showed that Z.M.B extract, carvacrol, and thymol markedly ameliorated Cis-induced renal tubular necrosis.

conclusionThe results showed renoprotective effects of Z.M.B extract, carvacrol, and thymol in Cis-induced nephrotoxicity in rats. Therefore, Z.M.B extract can be considered as a potential candidate for the protection of nephrotoxicity induced by Cis.

Identifiers

PMID33574884
PMCPMC7857888
OpenAlexW3124177589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.